S-1CIK 0001806540
Lycia Therapeutics, Inc.
IPO registration (S-1) filed .
Registration statement filed by a company planning to issue securities to the public for the first time.
New to the S-1? What it is and how to read oneFiling facts
- Accession number
- 0001628280-26-064973
- Filer
- Lycia Therapeutics, Inc.
- CIK
- 0001806540
- Form type
- S-1
- Form description
- IPO registration
- Filed at
- October 5, 2026
- Industry
- SIC 2836Biological Products
- Last verified
- October 6, 2026SecFilingDex pulls from EDGAR with daily cadence
Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1806540/000162828026064973/0001628280-26-064973-index.htm ↗Filer's full EDGAR submission history
EDGAR · Lycia Therapeutics, Inc. (0001806540) ↗Machine-readable JSON twin (LLM-citation friendly)
/api/filing/0001628280-26-064973.jsonSecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.